The Development of a Permanent Implantable Spacer with the Function of Size Adjustability for Customized Treatment of Regurgitant Heart Valve Disease

Author:

Chon Min-Ku1ORCID,Jung Su-Jin2ORCID,Seo Jae-Young2ORCID,Shin Dong-Hoon3,Park Jun-Hui4,Kim Hyun-Sook5,Hahn Joo-Yong6,Kim Eun-Kyoung6,Lee Seung-Whan7,Park Yong-Hyun1,Lee Sang-Hyun1,Kim June-Hong1ORCID

Affiliation:

1. Department of Cardiology, School of Medicine, Pusan National University, Cardiovascular Center, Yangsan Hospital, Yangsan 50612, Republic of Korea

2. Department of Research Strategy Team, R&D Center, TAU MEDICAL Inc., Yangsan 50612, Republic of Korea

3. Department of Pathology, School of Medicine, Yangsan Hospital, Pusan National University, Yangsan 50612, Republic of Korea

4. Major of Human Bioconvergence, Division of Smart Healthcare, Pukyong National University, Busan 48513, Republic of Korea

5. Division of Cardiology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang 14068, Republic of Korea

6. Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea

7. Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea

Abstract

The Pivot Mandu is an innovative device featuring a leak-tight adjustable 3D balloon spacer, incorporating inner mesh support, an outer e-PTFE layer, and a compliant balloon in the middle layer with a specialized detachable system. To assess its feasibility, proof of concept was rigorously evaluated through bench testing and survival porcine animal experiments. The results demonstrated successful remote inflation of the balloon system, with the balloon spacer exhibiting sustained patent and functional integrity over an extended observation period of up to 6 months. A noteworthy feature of the newly designed 3D balloon spacer is its capability for easy size adjustment during procedures, enhancing its adaptability and practicality in clinical settings. This three-layered 3D balloon spacer, with its established long-term patency, exhibits highly encouraging outcomes that hold promise in overcoming the current limitations of spacer devices for heart valve diseases. Given the compelling results from preclinical investigations, the translation of the Pivot Mandu into human trials is strongly warranted.

Funder

Kora government

Publisher

MDPI AG

Subject

Bioengineering

Reference22 articles.

1. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: A propensity score analysis;Thourani;Lancet,2016

2. Mitral loop cerclage as a variant form of mitral cerclage annuloplasty that adds a device (CSTV) for preventing potential complications: A preclinical proof of concept and feasibility study;Kim;Eurointerv. J. Eur. Collab. Work. Group Interv. Cardiol. Eur. Soc. Cardiol.,2016

3. Transcatheter tricuspid valve interventions: Landscape, challenges, and future directions;Asmarats;J. Am. Coll. Cardiol.,2018

4. Long-term outcomes of the FORMA transcatheter tricuspid valve repair system for the treatment of severe tricuspid regurgitation: Insights from the first-in-human experience;Asmarats;JACC Cardiovasc. Interv.,2019

5. Preclinical in vivo long-term evaluation of the novel Mitra-Spacer technology: Experimental validation in the ovine model;Peppas;Eurointerv. J. Eur. Collab. Work. Group Interv. Cardiol. Eur. Soc. Cardiol.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3